Investigators compared the outcomes of patients with type 2 diabetes who continued versus stopped metformin after progressing to stage 4 chronic kidney disease.

Though highly effective, medications for the prevention of chronic kidney disease progression are under-utilized, emphasizing the need for better use of prognostic tools.

Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...

The dual SGLT1/2 inhibitor sotagliflozin (Inpefa) reduced the risk for myocardial infarction (MI) and stroke in high-risk ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

Because SGLT2 inhibitors act on the kidney, and the amount of glucose excreted is closely dependent on the glomerular filtration rate (GFR), it can be anticipated that SGLT2 inhibitors will have a ...

Median estimated glomerular filtration rate (eGFR) at baseline was 88 mL/min ... “Our study suggests that SGLT2 inhibitors may provide benefit in slowing the progression of kidney disease ...

The National Institute for Nephrology Dialysis and Transplantation (NINDT) has planned a series of events to mark this ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

Median estimated glomerular filtration rate (eGFR) at baseline was 88 mL/min/1.73m 2 ... “Our study suggests that SGLT2 inhibitors may provide benefit in slowing the progression of kidney disease, ...

Blood tests for Serum Creatinine and eGFR (estimated Glomerular Filtration Rate) needs to be assessed ... in treating Diabetic Kidney Disease? A. SGLT2 Inhibitors (Sodium-Glucose co-transporter ...